Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series

被引：0
|
作者：
Patrick Terheyden
Cord Sunderkötter
Franz-Dietmar Söhngen
Linda Golle
Sonja Schimo
Ralf Baron
Christian Maihöfner
Andreas Binder
Wolfram Pönisch
机构：
[1] University of Lübeck,Department of Dermatology
[2] Martin Luther University Halle-Wittenberg,Department of Dermatology and Venereology, University Hospital Halle (Saale)
[3] Hospital Altenburger Land GmbH,Department of Hematology and Oncology
[4] Biotest AG,Division of Neurological Pain Research and Therapy, Department of Neurology
[5] University Hospital Schleswig-Holstein,Department of Neurology, General Fürth Hospital
[6] University of Erlangen,Department of Neurology
[7] Hospital Saarbrücken gGmbH,Hematology and Cell Therapy, Medical Clinic and Policlinic 1, University Hospital Leipzig
[8] University of Leipzig,undefined
来源：
Dermatology and Therapy | 2023年 / 13卷
关键词：
Generalized lesions; Herpes zoster; Hyperimmunoglobulin; Immunocompromised; VZV; Varitect CP; VZV-IgG;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2461 / 2471
页数：10
相关论文
共 50 条
  • [31] Investigation of Varicella Zoster virus-specific T cell responses
    Jones, L
    Ogg, GS
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (04) : 847 - 848
  • [32] Herpes Zoster Oticus Associated with Varicella Zoster Virus Encephalitis
    Eskiizmir, Goerkem
    Uz, Uzdan
    Taskiran, Esra
    Unlu, Halis
    LARYNGOSCOPE, 2009, 119 (04): : 628 - 630
  • [33] Detection of varicella zoster virus DNA in blood from immunocompromised patients during the week preceding the onset of herpes zoster rash
    Guiraud, Vincent
    Thevenet, Henri
    Boutolleau, David
    JOURNAL OF CLINICAL VIROLOGY, 2023, 169
  • [34] Phenotype and Functionality of Varicella Zoster Virus-Specific Cellular Immunity as Correlate of Protection in Immunocompetent and Immunocompromised Individuals
    Schub, D.
    Hennes, P.
    Rohrer, T.
    Sester, U.
    Sester, M.
    Schmidt, T.
    TRANSPLANTATION, 2012, 94 (10) : 542 - 542
  • [35] Varicella Zoster Virus (VZV) Infection in Immunocompromised Patients: Treatment with Specific Human VZV Polyclonal Immunoglobulins
    Sellier-Leclerc, A. -L.
    Aoun, B.
    Baudouin, V.
    Kwon, T.
    Deschenes, G.
    Ulinski, T.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1898 - 1898
  • [36] VARICELLA-ZOSTER VIRUS-INFECTION IN IMMUNOCOMPROMISED PATIENTS
    MASAOKA, T
    HIRAOKA, A
    TESHIMA, H
    TOMINAGA, N
    JOURNAL OF MEDICAL VIROLOGY, 1993, : 82 - 84
  • [37] Varicella zoster virus vaccineReactivation of Herpes Zoster secondary to vaccine failure: case report
    Reactions Weekly, 2017, 1672 (1) : 263 - 263
  • [38] ZOSTER IMMUNE PLASMA FOR PREVENTION OR TREATMENT OF VARICELLA-ZOSTER INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
    BALFOUR, HH
    GROTH, KE
    MCCULLOUGH, JJ
    KALIS, JM
    MARKER, SC
    SIMMONS, RL
    NAJARIAN, JS
    CLINICAL RESEARCH, 1976, 24 (04): : A545 - A545
  • [39] Genotype of Varicella Zoster Virus Isolated from Korean Elderly Patients with Herpes Zoster
    Choi, Young Ju
    Kim, Kye Hyung
    Don-Oh, Myoung
    INFECTION AND CHEMOTHERAPY, 2010, 42 (03): : 162 - 170
  • [40] Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster
    Suzuki, K
    Yoshikawa, T
    Tomitaka, A
    Matsunaga, K
    Asano, Y
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (06): : 1009 - 1012
12345